AstraZeneca board to consider delisting proposal next week

March 13, 2014 07:03 pm | Updated November 07, 2016 11:11 pm IST - New Delhi

AstraZeneca Pharma India on Thursday said its board will meet later this week to consider delisting the company from various bourses including the BSE and the National Stock Exchange.

“The voluntary delisting proposal from AstraZeneca Pharmaceuticals AB, Sweden (AZP AB) in terms of their letter dated March 1, 2014 will be considered at the meeting of the board of directors of the company on March 15,” AstraZeneca Pharma India said in a filing to the BSE.

Earlier this month, AstraZeneca Pharma had received by email a letter from AZP AB Sweden, promoter of the company, proposing to make a voluntary delisting offer to the public shareholders from BSE, NSE and Bangalore Stock Exchange.

Astrazeneca Pharmaceuticals AB holds 75 per cent in AstraZeneca Pharma India.

AstraZeneca Pharma shares closed at Rs. 1,065.85 apiece on the BSE, down 2.06 per cent.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.